GlassScriptPhysician profile
Christopher Falgout
NPI 1801531249
$3,172.14
in general payments reported to CMS, 2019-2025
31 companies · $806 in 2025
The $806 reported for 2025 was more than what 84% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $553 · 2023: $980 · 2024: $834 · 2025: $806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,619.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $641.21 | 2022-2025 | Uptravi, Opsumit |
| Novo Nordisk INC | $272.25 | 2024-2025 | Wegovy, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $230.75 | 2022-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $225.02 | 2022-2025 | Farxiga, Wainua |
| Lexicon Pharmaceuticals, INC. | $218.92 | 2023-2024 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $209.62 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $207.99 | 2022-2025 | Verquvo |
| Impulse Dynamics (USA) INC. | $147.76 | 2022-2023 | Optimizer |
| Medtronic, INC. | $111.40 | 2022 | |
| Chiesi USA, INC. | $107.91 | 2022-2023 | Cleviprex, Kengreal |
| Abiomed | $90.51 | 2025 | |
| Amgen INC. | $88.74 | 2023-2025 | Repatha, Repatha |
| Kiniksa Pharmaceuticals, LTD. | $63.31 | 2022-2023 | Arcalyst |
| Pfizer INC. | $62.92 | 2024 | |
| Irhythm Technologies, INC. | $47.06 | 2023-2024 | Zio Xt Patch, Zio Monitor |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $43.17 | 2024 | Bodyguardian, Watchman Flx |
| Novartis Pharmaceuticals Corporation | $42.60 | 2025 | |
| Bridgebio Pharma, INC. | $37.58 | 2025 | Attruby |
| Scpharmaceuticals INC. | $37.27 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.41 | 2023-2025 | Lifevest |
| Esperion Therapeutics, INC. | $32.46 | 2024-2025 | Nexletol |
| United Therapeutics Corporation | $31.45 | 2023 | Tyvaso |
| Janssen Pharmaceuticals, INC | $31.28 | 2022 | |
| Surmodics, INC. | $26.61 | 2022 | |
| Angiodynamics, INC. | $25.22 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $20.94 | 2024 | Arcalyst |
| Cvrx, INC. | $19.39 | 2023 | Barostim Neo System |
| Takeda Pharmaceuticals U.S.A., INC. | $19.24 | 2025 | Livtencity |
| Baxter Healthcare | $19.24 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Kestra Medical Technology Services, INC. | $13.78 | 2025 | Assure Wcd |
| Inari Medical, INC. | $12.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Falgout listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.